Published in PLoS Pathog on May 02, 2008
Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41
Identifying changes in selective constraints: host shifts in influenza. PLoS Comput Biol (2009) 1.67
Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog (2010) 1.57
The role of genomics in tracking the evolution of influenza A virus. PLoS Pathog (2009) 1.39
Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A (2013) 1.34
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses (2014) 1.18
A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface (2010) 1.13
Modelling heterotachy in phylogenetic inference by reversible-jump Markov chain Monte Carlo. Philos Trans R Soc Lond B Biol Sci (2008) 1.08
Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin. PLoS Curr (2009) 1.06
Influenza virus antigenic variation, host antibody production and new approach to control epidemics. Virol J (2009) 1.04
Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS One (2010) 1.03
Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J Virol (2012) 1.02
Charting the host adaptation of influenza viruses. Mol Biol Evol (2010) 0.96
Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One (2012) 0.95
Influenza A gradual and epochal evolution: insights from simple models. PLoS One (2009) 0.93
A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2. Bioinformatics (2010) 0.93
Nonadaptive Amino Acid Convergence Rates Decrease over Time. Mol Biol Evol (2015) 0.91
Gnarled-trunk evolutionary model of influenza A virus hemagglutinin. PLoS One (2011) 0.90
Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. J Immunol (2013) 0.90
Strain-specific antiviral activity of iminosugars against human influenza A viruses. J Antimicrob Chemother (2014) 0.88
Variation in the analysis of positively selected sites using nonsynonymous/synonymous rate ratios: an example using influenza virus. PLoS One (2011) 0.86
Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites. Influenza Other Respir Viruses (2013) 0.86
The effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humans. Elife (2015) 0.85
The evolutionary pattern of glycosylation sites in influenza virus (H5N1) hemagglutinin and neuraminidase. PLoS One (2012) 0.80
Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. Mol Cell Proteomics (2016) 0.80
Combining mutual information with structural analysis to screen for functionally important residues in influenza hemagglutinin. Pac Symp Biocomput (2009) 0.79
Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis? World J Biol Chem (2010) 0.78
Complete genome sequence of human astrovirus genotype 6. Virol J (2010) 0.78
Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. J Gen Virol (2016) 0.77
Sequence amplification via cell passaging creates spurious signals of positive adaptation in influenza virus H3N2 hemagglutinin. Virus Evol (2016) 0.76
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection. J Infect Dis (2015) 0.76
Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection. Immunology (2016) 0.76
Bioinformatics studies of Influenza A hemagglutinin sequence data indicate recombination-like events leading to segment exchanges. BMC Res Notes (2016) 0.75
Incorporating structure context of HA protein to improve antigenicity calculation for influenza virus A/H3N2. Sci Rep (2016) 0.75
Molecular characterization of partial-open reading frames 1a and 2 of the human astroviruses in South Korea. Virol J (2010) 0.75
Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines. PLoS Pathog (2016) 0.75
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes. PLoS Pathog (2014) 0.75
Emergency surveillance of influenza during 2009 in the Chinese city of Qingdao. Influenza Other Respir Viruses (2010) 0.75
Computational Identification of Antigenicity-Associated Sites in the Hemagglutinin Protein of A/H1N1 Seasonal Influenza Virus. PLoS One (2015) 0.75
Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season. Infect Genet Evol (2017) 0.75
Molecular Dynamics Simulation of the Influenza A(H3N2) Hemagglutinin Trimer Reveals the Structural Basis for Adaptive Evolution of the Recent Epidemic Clade 3C.2a. Front Microbiol (2017) 0.75
Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro. Int J Nanomedicine (2017) 0.75
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol (1981) 67.56
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol (1994) 24.04
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
A general empirical model of protein evolution derived from multiple protein families using a maximum-likelihood approach. Mol Biol Evol (2001) 16.83
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
A new method of inference of ancestral nucleotide and amino acid sequences. Genetics (1995) 10.23
Predicting the evolution of human influenza A. Science (1999) 6.91
Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Mol Biol Evol (1993) 6.61
Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science (2006) 6.01
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Phylogenetic methods come of age: testing hypotheses in an evolutionary context. Science (1997) 5.13
Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97
The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci (2001) 4.74
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A (2002) 4.02
Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct (2006) 3.18
The classification of amino acid conservation. J Theor Biol (1986) 3.12
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol (2004) 2.79
Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J Mol Evol (2000) 2.78
Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis (1997) 2.25
X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology (2003) 2.23
Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol (2004) 2.11
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
GlyProt: in silico glycosylation of proteins. Nucleic Acids Res (2005) 1.97
N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92
Real value prediction of solvent accessibility from amino acid sequence. Proteins (2003) 1.86
Mathematical elegance with biochemical realism: the covarion model of molecular evolution. J Mol Evol (2001) 1.84
Maximum-likelihood phylogenetic analysis under a covarion-like model. Mol Biol Evol (2001) 1.79
Nitric oxide and virus infection. Immunology (2000) 1.78
Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J Gen Virol (2001) 1.71
Probabilistic reconstruction of ancestral protein sequences. J Mol Evol (1996) 1.51
N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol (2002) 1.29
Models of natural mutations including site heterogeneity. Proteins (1998) 1.28
Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res (2002) 1.22
Modeling evolution at the protein level using an adjustable amino acid fitness model. Pac Symp Biocomput (2000) 1.00
The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. Bioorg Med Chem (2000) 0.93
Using physical-chemistry-based substitution models in phylogenetic analyses of HIV-1 subtypes. Mol Biol Evol (1999) 0.89
Beyond Mutation Matrices: Physical-Chemistry Based Evolutionary Models. Genome Inform Ser Workshop Genome Inform (1997) 0.79
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature (2006) 6.00
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature (2008) 3.79
Why are proteins marginally stable? Proteins (2002) 2.74
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A (2012) 2.18
rtREV: an amino acid substitution matrix for inference of retrovirus and reverse transcriptase phylogeny. J Mol Evol (2002) 2.06
Why are proteins so robust to site mutations? J Mol Biol (2002) 1.87
Integrating influenza antigenic dynamics with molecular evolution. Elife (2014) 1.80
Identifying changes in selective constraints: host shifts in influenza. PLoS Comput Biol (2009) 1.67
Assessing the accuracy of ancestral protein reconstruction methods. PLoS Comput Biol (2006) 1.62
Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol (2007) 1.58
The interface of protein structure, protein biophysics, and molecular evolution. Protein Sci (2012) 1.54
Estimating the distribution of selection coefficients from phylogenetic data using sitewise mutation-selection models. Genetics (2011) 1.45
Amino acid coevolution induces an evolutionary Stokes shift. Proc Natl Acad Sci U S A (2012) 1.35
Influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J Gen Virol (2005) 1.28
Myocardial perfusion and function single photon emission computed tomography. J Nucl Cardiol (2006) 1.27
Probing conformational changes in neurotransmitter transporters: a structural context. Eur J Pharmacol (2003) 1.17
Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis (2005) 1.16
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog (2012) 1.13
Studies of structural changes in the M2 proton channel of influenza A virus by tryptophan fluorescence. Virus Res (2004) 1.12
Using non-homogeneous models of nucleotide substitution to identify host shift events: application to the origin of the 1918 'Spanish' influenza pandemic virus. J Mol Evol (2009) 1.11
Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res (2008) 1.10
Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol (2006) 1.09
Optimization of a new score function for the generation of accurate alignments. Proteins (2002) 1.08
Detecting distant homologs using phylogenetic tree-based HMMs. Proteins (2003) 1.05
Dimerization in aminergic G-protein-coupled receptors: application of a hidden-site class model of evolution. Biochemistry (2003) 1.00
Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding. Virology (2013) 0.98
Performance of an iterated T-HMM for homology detection. Bioinformatics (2004) 0.98
Depicting a protein's two faces: GPCR classification by phylogenetic tree-based HMMs. FEBS Lett (2003) 0.97
Assessing predictors of changes in protein stability upon mutation using self-consistency. PLoS One (2012) 0.96
Charting the host adaptation of influenza viruses. Mol Biol Evol (2010) 0.96
Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling. Mol Biol Evol (2010) 0.92
Strong evidence for protein epistasis, weak evidence against it. Proc Natl Acad Sci U S A (2014) 0.90
Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues. Bioorg Med Chem Lett (2008) 0.87
Predicting functional sites in proteins: site-specific evolutionary models and their application to neurotransmitter transporters. J Mol Biol (2004) 0.86
Conditional ablation of T-cell development by a novel viral ion channel transgene. Immunology (2002) 0.84
Stability and function of the influenza A virus M2 ion channel protein is determined by both extracellular and cytoplasmic domains. Arch Virol (2008) 0.83
Performance evaluation of a new algorithm for the detection of remote homologs with sequence comparison. Proteins (2002) 0.83
Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir. ChemMedChem (2009) 0.82
Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells. J Gen Virol (2007) 0.82
A model of the mechanisms of language extinction and revitalization strategies to save endangered languages. Hum Biol (2010) 0.80
Functionality and the evolution of marginal stability in proteins: inferences from lattice simulations. Evol Bioinform Online (2007) 0.80
Evolution of response dynamics underlying bacterial chemotaxis. BMC Evol Biol (2011) 0.80
The organization of two rRNA (rrn) operons of the slow-growing pathogen Mycobacterium celatum provides key insights into mycobacterial evolution. FEMS Microbiol Lett (2008) 0.80
Divergence, recombination and retention of functionality during protein evolution. Hum Genomics (2005) 0.79
Summary of the HESI consortium studies exploring circulating inhibin B as a potential biomarker of testis damage in the rat. Birth Defects Res B Dev Reprod Toxicol (2013) 0.78
Comparison of the activities of BM2 protein and its H19 and W23 mutants of influenza B virus with activities of M2 protein and its H37 and W41 mutants of influenza A virus. Arch Virol (2009) 0.78
Using evolutionary methods to study G-protein coupled receptors. Pac Symp Biocomput (2002) 0.77
The inhibin B response in male rats treated with two drug candidates. Birth Defects Res B Dev Reprod Toxicol (2013) 0.76
A model for the cytoplasmic domain of the influenza A virus M2 channel by analogy to the HIV-1 Vpu protein. Protein Pept Lett (2002) 0.76
Analytic markovian rates for generalized protein structure evolution. PLoS One (2012) 0.76
The evolution of collective restraint: policing and obedience among non-conjugative plasmids. PLoS Comput Biol (2013) 0.75
[Impact of avian influenza virus H5N1 neuraminidase mutations on the activity of neuraminidase and the sensibility to neuraminidase inhibitors]. Zhonghua Yi Xue Za Zhi (2010) 0.75
Second isirv antiviral group conference: overview. Influenza Other Respir Viruses (2013) 0.75
In silico biology. Pac Symp Biocomput (2010) 0.75